|4Sep 26, 7:04 PM ET

Dupont Jakob 4

4 · Pyxis Oncology, Inc. · Filed Sep 26, 2023

Insider Transaction Report

Form 4
Period: 2023-09-22
Dupont Jakob
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-09-22+392,461392,461 total
    Exercise: $1.60Exp: 2033-09-22Common Stock (392,461 underlying)
Footnotes (1)
  • [F1]These stock options vest in three equal annual installments beginning on the first anniversary of August 23, 2023, subject to the reporting person's continued service through the applicable vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION